Comparison of in-vivo anti-fibrotic effects of pirfenidone and nintedanib in bleomycin-induced pulmonary fibrosis model
X. Li (Tianjin, China), Z. Lv (Tianjin, China), K. Huang (Tianjin, China), W. Gan (Tianjin, China), S. Gao (Tianjin, China), B. Yang (Tianjin, China), K. Helian (Tianjin, China), H. Zhou (Tianjin, China)
Source: International Congress 2019 – Translational aspects of idiopathic pulmonary fibrosis
Session: Translational aspects of idiopathic pulmonary fibrosis
Session type: Poster Discussion
Number: 5377
Disease area: Interstitial lung diseases
Rating: 
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
X. Li (Tianjin, China), Z. Lv (Tianjin, China), K. Huang (Tianjin, China), W. Gan (Tianjin, China), S. Gao (Tianjin, China), B. Yang (Tianjin, China), K. Helian (Tianjin, China), H. Zhou (Tianjin, China). Comparison of in-vivo anti-fibrotic effects of pirfenidone and nintedanib in bleomycin-induced pulmonary fibrosis model. 5377
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you: